Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) was $23.40 for the day, up 1.34% from the previous closing price of $23.09. In other words, the price has increased by $1.34 from its previous closing price. On the day, 0.92 million shares were traded. CPRX stock price reached its highest trading level at $23.73 during the session, while it also had its lowest trading level at $23.07.
Ratios:
Our analysis of CPRX’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.31 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.84. For the most recent quarter (mrq), Quick Ratio is recorded 4.92 and its Current Ratio is at 5.11. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on February 04, 2025, initiated with a Outperform rating and assigned the stock a target price of $28.
On November 18, 2024, Stephens started tracking the stock assigning a Overweight rating and target price of $35.
On March 14, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $27.Citigroup initiated its Buy rating on March 14, 2024, with a $27 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 10 ’24 when Miller Steve sold 50,000 shares for $21.93 per share. The transaction valued at 1,096,350 led to the insider holds 686,996 shares of the business.
Miller Steve bought 50,000 shares of CPRX for $1,096,333 on Dec 10 ’24. On Nov 27 ’24, another insider, INGENITO GARY, who serves as the Chief Med. & Reg. Officer of the company, sold 12,000 shares for $22.72 each. As a result, the insider received 272,654 and left with 51,391 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CPRX now has a Market Capitalization of 2790988032 and an Enterprise Value of 2351949312. As of this moment, Catalyst’s Price-to-Earnings (P/E) ratio for their current fiscal year is 19.96, and their Forward P/E ratio for the next fiscal year is 16.23. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.06 while its Price-to-Book (P/B) ratio in mrq is 4.22. Its current Enterprise Value per Revenue stands at 5.108 whereas that against EBITDA is 11.124.
Stock Price History:
The Beta on a monthly basis for CPRX is 0.84, which has changed by 0.7270007 over the last 52 weeks, in comparison to a change of 0.208081 over the same period for the S&P500. Over the past 52 weeks, CPRX has reached a high of $24.64, while it has fallen to a 52-week low of $13.12. The 50-Day Moving Average of the stock is 6.33%, while the 200-Day Moving Average is calculated to be 21.87%.
Shares Statistics:
CPRX traded an average of 1.15M shares per day over the past three months and 953240 shares per day over the past ten days. A total of 119.27M shares are outstanding, with a floating share count of 105.41M. Insiders hold about 11.63% of the company’s shares, while institutions hold 76.60% stake in the company. Shares short for CPRX as of 1736899200 were 6625919 with a Short Ratio of 5.76, compared to 1734048000 on 5940869. Therefore, it implies a Short% of Shares Outstanding of 6625919 and a Short% of Float of 6.890000000000001.
